VivoSim Labs to Add Rat Liver Model to NAMkind Platform | VIVS Stock NewsStockTitan·Sep 1 at 04:05 AMVIVS-0.29%
VivoSim Labs faces Nasdaq minimum bid price deficiency notice, risks delisting if noncompliance persistsPUBT·Aug 21 at 08:06 PMVIVS-0.29%
Vulnerability and Resilience in Cross-Asset Rotation: A Stress Test from Energy to Crypto ETFsGlobal Report·Aug 18 at 10:12 AMINUV-1.46%VIVS-0.29%
Pre-market hot trades in US stocks: VivoSim Labs pre-market down 15.26%; VisionSys AI pre-market down 14.21%Price Alert·Aug 10 at 08:47 AMVIVS-0.29%VSA+0.61%
US Micro-Caps Pivot to AI Infrastructure and Reverse Splits Amid Nasdaq Compliance PressuresGlobal Report·Aug 9 at 09:12 AMGRRR+0.51%KALA-9.57%
VivoSim regains compliance with Nasdaq $2.5 million stockholders’ equity rulePUBT·Aug 6 at 12:08 PMVIVS-0.29%
Healthcare and Materials Firms Beat Targets as Consumer Segment Faces HeadwindsGlobal Report·Jul 30 at 09:13 AMAGI-1.91%SENS-2.73%
VivoSim Labs faces Nasdaq delisting risk after falling below $2.5 million stockholders’ equity requirementPUBT·Jul 24 at 08:08 PMVIVS-0.29%
VivoSim Labs rises 6% in after-hours trading on volume spikeUS Stock Market Update·Jul 21 at 09:21 PMVIVS-0.29%
